Epidemiology of Trachoma in Health District of Fria in 2014
Central African Journal of Public Health
Volume 5, Issue 6, December 2019, Pages: 261-265
Received: Sep. 17, 2019; Accepted: Oct. 5, 2019; Published: Oct. 16, 2019
Views 31      Downloads 15
Authors
Aly Sylla, Institute of African Tropical Ophthalmology, University of Sciences and Technology of Bamako, Bamako, Mali
Seydou Bakayoko, Institute of African Tropical Ophthalmology, University of Sciences and Technology of Bamako, Bamako, Mali
Pierre Louis Lamah, Faculty of Medicine, Gamal Adbel Nasser University of Conackry, Conackry, Guinea
Alexis Ouendouno, Faculty of Medicine, Gamal Adbel Nasser University of Conackry, Conackry, Guinea
Amadou Sylla, Faculty of Medicine, Gamal Adbel Nasser University of Conackry, Conackry, Guinea
André Goepogui, Faculty of Medicine, Gamal Adbel Nasser University of Conackry, Conackry, Guinea
Rodrigue Romuald Elien Gagnan Yan-Zaou-Tou, Institute of African Tropical Ophthalmology, University of Sciences and Technology of Bamako, Bamako, Mali
Rahim Cheikh Nagnan Diabate, Institute of African Tropical Ophthalmology, University of Sciences and Technology of Bamako, Bamako, Mali
Japhet Pobanou Thera, Institute of African Tropical Ophthalmology, University of Sciences and Technology of Bamako, Bamako, Mali
Article Tools
Follow on us
Abstract
Introduction: Trachoma is a chronic keratoconjunctivitis caused by Chlamydia trachomatis bacteria. An epidemiological study was conducted in 2014 in the Health District of Fria (Northern Guinea province) to assess the prevalence of active and scar trachoma in a suspected endemic area of approximately 120-135 inhabitants. This is a transversal, descriptive, clustered survey of a representative sample of the population according to the standard protocol recommended by the World Health Organization (WHO). The clinical review of target populations was conducted according to WHO codification. Of the 3173 subjects recorded, 3159 subjects consented to be examined or an examination rate of 99,55%. The prevalence of active trachoma was 8.67% (CI at 95% = 7.2 – 10.4). The prevalence of scar trachoma was 0.21%. The principal sources of water for households are surface water (41%) and drilling water (41%). The prevalence of active and scar trachoma, risk factors are discussed. In our study, trachoma appeared as a public health problem in the health district of Fria. The prevalence of active and scar trachoma is approaching WHO limit. Poor hygiene was the main risk factor. The implementation of the different components of the strategy SAFE in this locality is a necessity.
Keywords
Prevalence, Trachoma, Fria
To cite this article
Aly Sylla, Seydou Bakayoko, Pierre Louis Lamah, Alexis Ouendouno, Amadou Sylla, André Goepogui, Rodrigue Romuald Elien Gagnan Yan-Zaou-Tou, Rahim Cheikh Nagnan Diabate, Japhet Pobanou Thera, Epidemiology of Trachoma in Health District of Fria in 2014, Central African Journal of Public Health. Vol. 5, No. 6, 2019, pp. 261-265. doi: 10.11648/j.cajph.20190506.16
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Taylor HR, Burton MJ, Hadda D, West S, Wright H. Trachoma. Lancet, 2014; 384: 2142-2152.
[2]
Anne-Marie MOULIN, Jeanne ORFILA, Doulaye SACKO, Jean-François SCHEMANN. Lutte contre le trachome en Afrique Sub saharienne. Ed. IRD, Paris 2006. 225 pp. ISSN 1633-9924/ISBN 2-7099-1601-0.
[3]
World Health Organization. Rapport de situation sur l’élimination du trachome 2012. REH, 2013, 88 (24): 241-256.
[4]
P. Bensaid, P. Goldschmidt, P. Huguet, E. Einterz. Enquête de prévalence du trachome cécitant dans le district de Kolofata, nord Cameroun: déroulement pratique, résultats, perspectives de traitement. J. Fr. Ophtalmol. 2007, 30 (2): 2S302. https://doi.org/10.1016/S0181-5512(07)80341-X.
[5]
M. B. SAAL, J. F. SCHEMANN, B. SAAR, M. FAY E, G. MOMO, S. MARIOTTI, A. D. NEGREL. Le Trachome Au Senegal: Resultats d’une Enquete Nationale. Med Trop 2003; 63: 53-59.
[6]
GEOPOGUI A., HUGUET P., MARIOTTI S., P., TRAORE L., GODIN-BENHAIM C., NEGREL A. D., Trachome en Guinée (Conakry). Rev. Int. Trach. 2002, 77-79: 151-153.
[7]
Traoré L, Dembele B, Keita M, Reid SD, Dembele M, Mariko B, et al (2018) Prevalence of trachoma in the kayes region of Mali eight years after stopping mass drug administration. PLoS Negl Trop Dis 12 (2): e0006289.
[8]
Ayana Tsega Ferede, Abel Fekadu Dadi, Amare Tariku and Akelew Awoke Adane. Prevalence and determinants of active trachoma among preschool-aged children in Dembia District, Northwest Ethiopia. Infectious Diseases of Poverty, 2017, 6: 128.
[9]
Victor H. HU, Emma M. Harding-Esch, Matthew J. Burton, Robin L. Bailey, Julbert Kadimpeul and David C. W. Mabey. Epidemiology and control of trachoma: systematic review. Tropical Medicine and International Health. 2010, 15 (6): 673-691.
[10]
SCHEMANN. J. F., SACKO D., MALVY D., BANOU A., TRAORE L., MOMO G., 2002. Risk factors for trachoma. Int. J. Epidemiol, 31: 194-201.
[11]
SCHEMANN JEAN FRANÇOIS. «Le trachome, une maladie de la pauvreté», éd. IRD, Paris, 2008, 206 pp. ISBN: 978-2-7099-1646-2/ISSN: 1142-2580.
[12]
SCHEMANN. J. F. Trachome et xerophtalmie en Afrique; Deux maladies de société. Thèse sciences biol Med, Université victor Segalen, Bordeaux II. 2002.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186